Literature DB >> 25537670

K-Ras 4A Transcript variant is up-regulated in eutopic endometrium of endometriosis patients during proliferative phase of menstrual cycle.

Maryam Shahrabi-Farahani1, Shirin Shahbazi, Reza Mahdian, Soheila Amini-Moghaddam.   

Abstract

AIMS: K-Ras transcripts comprise two main isoforms: K-Ras 4A and K-Ras 4B, which act differently. The expression of both isoforms was reported in many human tissues. However, K-Ras 4B was the major expressed transcript variant. An increased expression of K-Ras 4B mRNA was reported in eutopic endometrium of endometriosis patients. In this way, we aimed to study the expression of K-Ras 4A transcript in eutopic endometrium related to endometriosis.
METHODS: Employing exon4-flanking primers, K-Ras isoforms were simultaneously amplified in a RT-PCR reaction. Quantitative real-time PCR was performed using GAPDH as an internal control. K-Ras 4A transcript expression in eutopic endometrium was analyzed by ΔΔC T method.
RESULTS: We identified existence of both of K-Ras 4A and K-Ras 4B in eutopic endometrium of patients and controls. Quantitative real-time analysis demonstrated that K-Ras 4A expression was 2.7-fold higher in endometriosis than non-endometriosis eutopic samples. Interestingly, this overexpression mainly occurs through the proliferative phase of menstrual cycle.
CONCLUSION: The findings bring to light the eminent role of K-Ras 4A in endometriosis. This splice variant which is known for promoting apoptosis could be an effective factor in balance between proliferation and death of eutopic endometrial cells.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25537670     DOI: 10.1007/s00404-014-3596-7

Source DB:  PubMed          Journal:  Arch Gynecol Obstet        ISSN: 0932-0067            Impact factor:   2.344


  3 in total

Review 1.  Malignant Transformation and Associated Biomarkers of Ovarian Endometriosis: A Narrative Review.

Authors:  Liudmila M Mikhaleva; Aleksandr I Davydov; Olga I Patsap; Elizaveta V Mikhaylenko; Vladimir N Nikolenko; Margarita E Neganova; Sergey G Klochkov; Siva G Somasundaram; Cecil E Kirkland; Gjumrakch Aliev
Journal:  Adv Ther       Date:  2020-05-08       Impact factor: 3.845

2.  Differential expression of mTOR components in endometriosis and ovarian cancer: Effects of rapalogues and dual kinase inhibitors on mTORC1 and mTORC2 stoichiometry.

Authors:  Karly-Rai Rogers-Broadway; Juhi Kumar; Cristina Sisu; Gurleen Wander; Emily Mazey; Jeyarooban Jeyaneethi; George Pados; Dimitris Tsolakidis; Eleftherios Klonos; Thomas Grunt; Marcia Hall; Jayanta Chatterjee; Emmanouil Karteris
Journal:  Int J Mol Med       Date:  2018-10-31       Impact factor: 4.101

Review 3.  Cancer driver mutations in endometriosis: Variations on the major theme of fibrogenesis.

Authors:  Sun-Wei Guo
Journal:  Reprod Med Biol       Date:  2018-08-16
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.